Clinical Impact of New Rheumatoid Arthritis Findings From EULAR 2020 *

June 3-6, 2020; Virtual Meeting
Review the latest RA management data with Capsule Summaries and expert-authored commentaries covering key studies from EULAR 2020.

Share

Program Content

8 Capsule Summary Slidesets

Activities

VTE: Tofacitinib, Baricitinib
WHO VigiBase Analysis: Thromboembolic Safety of Tofacitinib, Baricitinib in Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 01, 2020

Expires: June 30, 2021

View Activity
JAK-POT
JAK-POT: Real-World Risk of Treatment Discontinuation Across 17 International Registers of Patients With Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 01, 2020

Expires: June 30, 2021

View Activity
Risk of HZ in RA Patients
RABBIT: Risk of Herpes Zoster Stratified by DMARD Type Among Patients With Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 01, 2020

Expires: June 30, 2021

View Activity
Upadacitinib Infections
Infection Incidence With Upadacitinib in Patients With Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2020

Expires: July 06, 2021

View Activity
FINCH 1 Wk 52
FINCH 1: 52-Wk Results of Filgotinib in Patients With Rheumatoid Arthritis With Inadequate Response to Methotrexate
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 13, 2020

Expires: July 12, 2021

View Activity
Dutch Biologic Monitor
Dutch Biologic Monitor: Fatigue Among Biologic Recipients Across a Range of Immune-Mediated Inflammatory Diseases
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 13, 2020

Expires: August 12, 2021

View Activity
SRQ
SRQ: VTE Risk Increases Alongside Disease Activity Among Swedish Patients With Rheumatoid Arthritis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 13, 2020

Expires: August 12, 2021

View Activity
SELECT-CHOICE
SELECT-CHOICE: Upadacitinib vs Abatacept in Patients With Rheumatoid Arthritis With Inadequate Response or Intolerance to bDMARDs
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2020

Expires: August 16, 2021

View Activity

Activities

RA Prevention and Treatment
Rheumatoid Arthritis Prevention and Treatment: My Top Studies From EULAR 2020
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2020

Expires: July 15, 2021

View Activity
JAK Inhibitors
EULAR 2020: New Data on JAK Inhibitors for Patients With RA
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2020

Expires: July 15, 2021

View Activity
RA Comorbidities
Comorbidities in Rheumatoid Arthritis: My Top Studies From EULAR 2020
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: August 24, 2020

Expires: August 23, 2021

View Activity
After DMARD Failure
Treating RA After DMARD Failure: Key Data From EULAR 2020
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 27, 2020

Expires: August 26, 2021

View Activity

Faculty

cover img faculity

Paul Emery, MA, MD, FRCP

Versus Arthritis, Professor of Rheumatology 
Leeds Institute of Rheumatic & Musculoskeletal Medicine
University of Leeds
Consultant, Rheumatology
Leeds Teaching Hospitals NHS Trust
Leeds, West Yorkshire

cover img faculity

Eric M. Ruderman, MD

Professor
Northwestern University Feinberg School of Medicine
Clinical Practice Director
Northwestern Medical Group
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AbbVie Inc.

Gilead Sciences, Inc.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.